ECM
MGNX icon

EMC Capital Management’s MacroGenics MGNX Stock Holding History

EMC Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-43,361
Closed -$696K – 341
2021
Q4 		$696K Hold
43,361
– – 0.37% 64
2021
Q3 		$847K Hold
43,361
– – 0.47% 58
2021
Q2 		$1.17M Buy
43,361
+8,493
+24% +$249K 0.66% 40
2021
Q1 		$1.11M Buy
34,868
+9,837
+39% +$239K 0.79% 42
2020
Q4 		$572K Buy
+25,031
New +$576K 0.44% 69

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EMC Capital Management's MGNX Position: Q1 2022 in Review

EMC Capital Management sold out of MacroGenics (MGNX) in Q1 2022, closing a stake of 43,361 shares — an estimated $696K sold.

EMC Capital Management first reported a position in MGNX in Q4 2020 and held it in 5 quarters. The position peaked at $1.17M in Q2 2021. 144 funds tracked by Wall St. Rank hold MGNX as of Q1 2022.

  • EMC Capital Management reported no remaining MacroGenics position as of Q1 2022 after selling out during the quarter.
  • EMC Capital Management sold 43,361 MacroGenics shares in Q1 2022, an estimated $696K.
  • EMC Capital Management first reported a position in MacroGenics in Q4 2020 and held it in 5 quarters.
  • EMC Capital Management's MacroGenics position peaked at $1.17M in Q2 2021.
  • 144 funds tracked by Wall St. Rank held MacroGenics as of Q1 2022.

Based on EMC Capital Management's 13F filing for Q1 2022, filed 16 May 2022.